Acura Pharmaceuticals Insider Trades

ACUR

Track insider trading activity from Acura Pharmaceuticals executives and directors. See which insiders are buying and selling ACUR stock.

Trades Last 12 Months

ACUR Price

All Insider Trades for Acura Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ross George K Director
Holding Value $119 595,903 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25 50,000 shares
$0.00
$0.00
Holding Value $10 50,000 shares
Last Trade
Jan 02, 2026 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25 50,000 shares
$0.00
$0.00
Skelly William G Director
Holding Value $135 675,989 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25 50,000 shares
$0.00
$0.00
Wesson Bruce F Director
Holding Value $0 0 shares
Last Trade
Jan 02, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$0.00
Brzeczko Albert W See Remarks
Holding Value $97.2 486,001 shares
Last Trade
Nov 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Jones Robert B President & CEO
Holding Value $0 0 shares
Last Trade
Nov 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Seiser Robert A Vp, Treasurer & Controller
Holding Value $87.7 438,254 shares
Last Trade
Nov 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Clemens Peter A Senior VP & CFO
Holding Value $109 545,430 shares
Last Trade
Nov 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Holding Value $0 0 shares
Last Trade
Jun 09, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$0.00
Emigh James F Vp, Corporate Development
Holding Value $0 0 shares
Last Trade
Feb 24, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Holding Value $0 0 shares
Last Trade
Dec 14, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.00
Rivet J Bradley VP Marketing
Holding Value $2.8 14,000 shares
Last Trade
Dec 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Holding Value $812 4,058,337 shares
Last Trade
Feb 28, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.00
Holding Value $3 15,000 shares
Last Trade
Jan 02, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Holding Value $103 512,901 shares
Last Trade
Oct 01, 2012 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.00
Gce Holdings Llc 10% owner
Holding Value $0 0 shares
Last Trade
Oct 01, 2012 Sale (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.00
Azad David Director
Holding Value $3 15,000 shares
Last Trade
Jan 03, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Reddick Andrew D President And CEO
Holding Value $214 1,067,609 shares
Last Trade
Apr 04, 2011 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Sumner William Director
Holding Value $3 15,000 shares
Last Trade
Jan 03, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Boehm Garth VP Mod. Rel. Dosage Form Dev.
Holding Value $19.2 96,000 shares
Last Trade
May 11, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up